What happens when endoscopy shows shallow gastric erosions but there is no active bleeding-and how is the underlying cause identified?
Michael’s path through EGD review, cause identification, treatment, healing, and follow-up
Your guardians. GastroDoxs GutGuardians™ is our team of board-certified gastroenterologists - a physician-led defense force of specialists, systems, and solution pathways working together to protect, detect, solve, and defend your digestive health through expert GI evaluation, advanced diagnostic screening, and endoscopic evaluation - commanded from your first concern to your last follow-up, and every critical stage in between.
A 46-year-old operations director navigating nonbleeding gastric erosions
Michael developed persistent upper abdominal burning, nausea, early fullness, and meal-related discomfort that no longer behaved like occasional indigestion.
He had no hematemesis, coffee-ground emesis, melena, syncope, or laboratory evidence of acute blood loss.
EGD showed several shallow antral erosions without active bleeding or a deep gastric ulcer, and gastric testing confirmed Helicobacter pylori infection.
His journey focused on H. pylori eradication, acid suppression during healing, medication review, confirmation of cure, and reassessment if symptoms persisted.
The erosions showed surface injury, but the important question was why they formed. H. pylori testing changed the treatment plan.
Michael first noticed intermittent burning after meals and coffee.
Symptoms became more frequent and were accompanied by nausea and early fullness.
The lack of overt bleeding reduced immediate bleeding concern but did not explain the mucosal injury.
Endoscopy separated shallow gastric erosions from a deeper ulcer or malignant-appearing lesion.
The turning point came when Michael understood why the erosion itself did not identify the underlying mechanism.
Michael expected the endoscopy result to be the diagnosis and treatment by itself.
The GI team explained that NSAIDs, alcohol, H. pylori, bile reflux, critical illness, and other causes can injure the gastric lining.
Biopsy-based H. pylori testing gave the erosions a treatable underlying cause.
Treatment included eradication therapy rather than indefinite acid suppression alone.
A test of cure was planned because symptom improvement does not prove that H. pylori has been eradicated.
The plan needed to confirm nonbleeding status, identify the likely cause, remove modifiable injury risks, and define what persistent symptoms would mean.
The team documented pain, nausea, vomiting, early fullness, stool color, anemia history, weight change, and alarm symptoms.
NSAIDs, aspirin, alcohol, anticoagulants, steroids, supplements, smoking, and prior H. pylori therapy were reviewed.
The stomach was assessed for erosion location, depth, ulceration, active bleeding, nodularity, mass, retained bile, and other mucosal abnormalities.
Michael received eradication therapy, acid suppression, medication guidance, and a test-of-cure plan.
GastroDoxs can review EGD findings, gastric biopsies, H. pylori testing, NSAID or aspirin exposure, alcohol, prior surgery, dyspepsia, and healing strategy.
The pathway moved from persistent dyspeptic symptoms to EGD, bleeding-status assessment, cause identification, healing therapy, and follow-up.
Michael first noticed intermittent burning after meals and coffee.
Review dyspepsia →Endoscopy separated shallow gastric erosions from a deeper ulcer or malignant-appearing lesion.
Review upper endoscopy →Gastric pathology and H. pylori testing were interpreted with PPI, antibiotic, and bismuth exposure.
Review erosive gastropathy →A guideline-based eradication regimen was selected according to prior antibiotic exposure, allergies, and current recommendations.
Schedule follow-up →The next step depends on bleeding status, H. pylori, NSAIDs and other irritants, ulceration, biopsy findings, prior surgery, critical illness, and persistent symptoms.
History, blood counts, stool color, vital signs, and EGD findings establish whether the pathway is truly nonbleeding.
Confirmed H. pylori infection changes management because eradication treats an important cause of peptic disease.
NSAIDs, aspirin, alcohol, anticoagulants, steroids, supplements, smoking, and prior H. pylori therapy were reviewed.
A guideline-based eradication regimen was selected according to prior antibiotic exposure, allergies, and current recommendations.
Ongoing symptoms prompted review for persistent H. pylori, functional dyspepsia, ulcer disease, biliary disease, or another cause.
New black tarry stool, vomiting blood, coffee-ground emesis, fainting, progressive weakness, or severe abdominal pain changes this from a nonbleeding pathway to urgent evaluation.
Symptoms, EGD findings, erosion depth and distribution, bleeding status, medications, H. pylori, biopsy findings, exposures, and prior surgery are interpreted together.
Erosions are shallower than ulcers and can occur with reactive, infectious, medication-related, or stress-related gastric injury.
Confirmed H. pylori infection changes management because eradication treats an important cause of peptic disease.
A patient may have erosions without hematemesis, melena, anemia, or endoscopic active bleeding.
Eradication therapy, NSAID withdrawal, alcohol reduction, acid suppression, or other treatment depends on the underlying mechanism.
Ongoing dyspepsia can reflect persistent infection, medication injury, functional dyspepsia, ulcer disease, biliary disease, or another diagnosis.
The visit connected symptoms, endoscopy, pathology, medication and exposure history, bleeding risk, and the most likely cause.
The team documented pain, nausea, vomiting, early fullness, stool color, anemia history, weight change, and alarm symptoms.
NSAIDs, aspirin, alcohol, anticoagulants, steroids, supplements, smoking, and prior H. pylori therapy were reviewed.
The stomach was assessed for erosion location, depth, ulceration, active bleeding, nodularity, mass, retained bile, and other mucosal abnormalities.
Gastric pathology and H. pylori testing were interpreted with PPI, antibiotic, and bismuth exposure.
Michael received eradication therapy, acid suppression, medication guidance, and a test-of-cure plan.
Treatment was directed at the cause while acid suppression and mucosal healing were used according to the clinical context.
A guideline-based eradication regimen was selected according to prior antibiotic exposure, allergies, and current recommendations.
A PPI supported symptom control and mucosal recovery.
NSAIDs and other contributing medicines or exposures were reviewed rather than continued automatically.
A non-serologic test of cure was planned after treatment using appropriate timing and medication holds.
Ongoing symptoms prompted review for persistent H. pylori, functional dyspepsia, ulcer disease, biliary disease, or another cause.
New melena, hematemesis, coffee-ground emesis, fainting, or marked weakness required urgent evaluation.
Nonbleeding gastric erosions may reflect infection, medications, chemical injury, alcohol, or critical illness and should be interpreted with the full upper-GI picture.
The stomach was assessed for erosion location, depth, ulceration, active bleeding, nodularity, mass, retained bile, and other mucosal abnormalities.
Gastric pathology and H. pylori testing were interpreted with PPI, antibiotic, and bismuth exposure.
NSAIDs, aspirin, alcohol, anticoagulants, steroids, supplements, smoking, and prior H. pylori therapy were reviewed.
New melena, hematemesis, coffee-ground emesis, fainting, or marked weakness required urgent evaluation.
Coverage may differ for office consultation, H. pylori testing, pathology review, EGD, laboratory studies, and repeat endoscopy when indicated.
Provide endoscopy images and details about erosion location, ulceration, bleeding, and other upper-GI findings.
Include biopsy findings and prior infection-treatment records.
Include NSAIDs, aspirin, anticoagulants, steroids, iron, bismuth, and over-the-counter products.
Report black stool, vomiting blood, dizziness, anemia, persistent nausea, vomiting, pain, and weight change.
The plan matched the most likely cause, bleeding status, pathology, medication needs, symptoms, and whether the erosions were likely to explain the clinical picture.
Erosions are shallower than ulcers and can occur with reactive, infectious, medication-related, or stress-related gastric injury.
Confirmed H. pylori infection changes management because eradication treats an important cause of peptic disease.
A guideline-based eradication regimen was selected according to prior antibiotic exposure, allergies, and current recommendations.
Ongoing symptoms prompted review for persistent H. pylori, functional dyspepsia, ulcer disease, biliary disease, or another cause.
The endoscopic finding can look similar while the underlying mechanism and treatment differ.
Requires eradication when infection is confirmed.
Best for: Confirmed H. pylori with compatible gastric injury
Limitations: Symptoms alone cannot diagnose infection
Takeaway: Treat the infection and confirm eradication
Requires medication-risk review, acid protection, and safer alternatives when possible.
Best for: Patients with repeated NSAID or antiplatelet exposure
Limitations: Stopping essential cardiovascular therapy without clinician input can be harmful
Takeaway: Coordinate medication changes rather than stopping them casually
Can relate to alcohol, bile exposure, or other irritants and is managed according to the specific exposure and anatomy.
Best for: Reactive pathology with a plausible chemical mechanism
Limitations: Evidence varies by cause
Takeaway: Remove or reduce the actual irritant
Occurs in severe physiologic illness and is managed in the context of the underlying critical condition.
Best for: Critically ill patients with meaningful stress-ulcer risk
Limitations: Does not mean everyday emotional stress caused the lesion
Takeaway: Reassess the need for prophylactic acid suppression after recovery
A previously nonbleeding gastric erosion can become clinically urgent if bleeding, perforation, severe vomiting, or progressive systemic symptoms develop.
How the H. pylori-associated gastric erosions without active bleeding journey changed symptoms, medication use, and safety monitoring
A guideline-based eradication regimen was selected according to prior antibiotic exposure, allergies, and current recommendations.
A PPI supported symptom control and mucosal recovery.
Ongoing symptoms prompted review for persistent H. pylori, functional dyspepsia, ulcer disease, biliary disease, or another cause.
Michael returned to daily activities with a clearer understanding of the erosion cause and which medicines or exposures required ongoing caution.
The patient understood that a new bleeding pattern would require a different and more urgent evaluation.
The erosions showed surface injury, but the important question was why they formed. H. pylori testing changed the treatment plan.
This global patient journey is an educational composite illustrating H. pylori-associated gastric erosions without active bleeding. It does not represent a specific patient. Gastric erosions are superficial mucosal breaks and can occur with H. pylori, NSAIDs, alcohol, chemical/reactive injury, or critical illness. Treatment depends on the cause, symptoms, bleeding status, pathology, medications, and other findings. Vomiting blood, coffee-ground emesis, black tarry stool, fainting, severe weakness, persistent vomiting, or severe abdominal pain requires prompt medical assessment.
Answers about erosions, ulcers, H. pylori, NSAIDs, alcohol, acid suppression, healing, bleeding warning signs, and follow-up
A gastric erosion is a superficial break in the stomach lining that is shallower than a peptic ulcer.
It means there is no current clinical or endoscopic evidence of active GI bleeding such as hematemesis, melena, acute blood-loss anemia, or active hemorrhage from the erosion.
Common causes include NSAIDs, alcohol, H. pylori-associated peptic injury, reactive chemical injury, and severe physiologic stress during critical illness.
No. Ulcers extend deeper into the gastric wall, while erosions are superficial mucosal defects.
Yes. H. pylori can contribute to gastric inflammation and peptic injury and should be treated when confirmed.
Yes. NSAIDs can injure the gastric lining and contribute to erosions and ulcers.
Treatment targets the cause and may include H. pylori eradication, stopping avoidable NSAIDs or irritants, acid suppression, and management of the underlying illness.
Not automatically. Repeat endoscopy depends on persistent or worsening symptoms, ulceration, concerning pathology, bleeding, or another unresolved clinical question.
Yes. New hematemesis, coffee-ground emesis, melena, dizziness, or anemia requires urgent reassessment.
Seek urgent care for vomiting blood, black tarry stool, fainting, severe weakness, persistent vomiting, or severe worsening abdominal pain.
Explore related condition, symptom, and procedure guides connected with gastric erosions.
Review superficial gastric injury, causes, bleeding risk, and treatment.
Condition Guide →Understand related gastric and duodenal disorders.
Stomach Guide →Review upper abdominal burning, post-meal fullness, early satiety, and nausea.
Dyspepsia Guide →Learn how upper endoscopy evaluates gastric erosions, ulcers, bleeding, and suspicious lesions.
EGD Guide →Arrange stable review of EGD findings, H. pylori, medication injury, dyspepsia, and healing strategy.
Book Appointment →Review EGD findings, erosion depth, ulceration, stool color, blood counts, and evidence of active or recent bleeding.
Assess H. pylori, NSAIDs, aspirin, alcohol, reactive chemical injury, critical illness, and prior gastric surgery.
A guideline-based eradication regimen was selected according to prior antibiotic exposure, allergies, and current recommendations.
A PPI supported symptom control and mucosal recovery.
Ongoing symptoms prompted review for persistent H. pylori, functional dyspepsia, ulcer disease, biliary disease, or another cause.
New melena, hematemesis, coffee-ground emesis, fainting, or marked weakness required urgent evaluation.
GastroDoxs can review EGD findings, gastric pathology, H. pylori testing, NSAID and aspirin exposure, alcohol, prior surgery, dyspepsia, and healing strategy.